Interview with Dominique Demolle , Co-founder & CEO, Aepodia
Having worked in internal clinical research for Eli Lilly for 14 years, from 1993 – 2007, what has this…
Aepodia
Last updated: 13.02.2014
Address: Avenue Albert Einstein 2A
1348 Louvain-la-Neuve
Belgium
Tel: +32 (0)10 39 20 11
Web: http://http/www.aepodia.com
Company description
Aepodia S.A. (spin-off of a top 10 US Pharma Company) was created in March 2007 by a group of experts in early-phase clinical development. Since then, our company has grown and built a strong and a worldwide reputation in the early clinical drug development sector. We have established solid and effective collaborations with world pharmaceutical leaders, as well as with small biotech companies. The management and staff members have a background in pharmaceutical development that allows us to understand sponsor requirements and challenges and to meet their needs in an optimal way.
Our headquarters are located in Louvain-La-Neuve, Belgium, with offices in Paris-La Défense, France. Thanks to our strategic location in the center of Europe, we can cover the European phase I units. We also support clinical trials in the United-States and Singapore and provide easy access to patients.
Products and services
Aepodia is a CRO sponsor representative providing customized services in Phase I/II clinical trials and in clinical development of Medical devices.
Interviews
Related
Jacques Marbehant – Senior Vice President, Head of Global Manufacturing,…
Belgian champion UCB’s global manufacturing head, Jacques Marbehant, talks candidly about managing a broad…
Belgium / New ‘Corona Commissioner’ to Coordinate COVID-19 Response
The new Belgian government has moved to streamline its response to the COVID-19 crisis with the appointment of…
Jan de Backer – CEO, Fluidda
Fluidda is the world leader in the field of functional respiratory imaging which combines HRCT scans and…
Kristel de Bisschop – General Manager, Pierre Fabre Benelux
Pierre Fabre Benelux General Manager Kristel de Bisschop discusses the challenges and opportunities inherent in…
Kevin Houdenaert – General Manager, Recordati Benelux & Nordics
Kevin Houdenaert, general manager for Benelux and the Nordics at Italian rare disease, specialty and primary care…
The Long Read / Belgium: The Multifaceted
Squirreled away in the lowlands of North West Europe and somewhat dwarfed by the mighty neighbouring pharmaceutical…
Pharma Faces / Sonja Willems, Janssen Benelux
Belgium is a vitally important country for Johnson & Johnson’s pharmaceutical arm, Janssen, globally. In…
In Profile / Stéphane De Wit, A Pioneer in HIV Research
Belgian doctor, researcher and professor, Stéphane De Wit has been with the St Pierre University Hospital in…
Hospital Reform in Belgium / A Guarantee of Better Care?
Belgium’s healthcare system was ranked fourth in Europe in 2019, outperforming its peers across a number of…
Carl Laurent – Managing Director, Siemens Healthineers BeLux
Carl Laurent, managing director and CEO of Siemens Healthineers BeLux, sits down with PharmaBoardroom to explain…
Axel De Muyt – General Manager & VP, Novo Nordisk Belgium
Axel De Muyt, general manager & VP of Novo Nordisk Belgium and Luxembourg, recounts his journey through the…
Cell & Gene Therapy Launches / Zolgensma® in Belgium: Lessons Learned
In late 2019 Novartis hit the headlines in Belgium after it refused to grant access to its one-off gene therapy…
